Neonatal Tetanus

Neonatal tetanus is tetanus occurring in newborns, and is identified in the source material as one of the major clinical forms of tetanus ^[2]. The etiologic agent is *Clostridium tetani*, a spore-forming bacterium that is widespread in the environment and cannot be eradicated ^[1][3]. The available snippets characterize the disease as preventable through vaccination and post-exposure wound care, but do not provide a more detailed disease-definition statement specific to neonatal cases ^[3].

The source material gives limited neonatal-specific symptom detail, but tetanus overall is described as producing muscle spasms, rigidity, and dysautonomia through a potent neurotoxin ^[1]. Important complications mentioned for tetanus include laryngeal spasm with possible airway obstruction and respiratory arrest, nosocomial infections, and sequelae of prolonged immobility ^[1]. A broader clinical classification of tetanus includes generalized, cephalic, localized, and neonatal forms ^[2]. Source-backed detail on the typical neonatal course, severity pattern, or neonatal-specific complications is not yet available in these snippets.

Neonatal tetanus is reported as particularly common in developing countries, with the cited review linking this pattern to unhygienic childbirth practices, social taboos, and improper immunization of pregnant mothers ^[2]. Tetanus more broadly remains an important vaccine-preventable cause of morbidity and mortality, notably in southern Asia, southeast Asia, and sub-Saharan Africa ^[1]. The source material also notes that deaths from tetanus fell by almost 90% between 1990 and 2019, largely reflecting the success of the WHO Maternal and Neonatal Tetanus Elimination campaign ^[1]. A separate review states that the causative organism is widespread worldwide and cannot be eradicated, and that many children and adults, particularly men, may remain unprotected because of inadequate booster immunization ^[3].

The available sources indicate that tetanus results from infection with *Clostridium tetani* and is usually acquired via contaminated wounds and burns ^[1]. For neonatal tetanus, the snippets specifically point to unhygienic childbirth practices as an important contextual factor, but they do not further specify the exact exposure pathway ^[2]. Source-backed detail on persistence of transmission, environmental reservoirs beyond general ubiquity, or person-to-person spread is not yet available in these snippets ^[3].

The snippets identify newborns as the affected population and describe neonatal tetanus as particularly common in developing countries ^[2]. They also point to pregnant mothers with inadequate immunization coverage as an important upstream risk context, and to births occurring under unhygienic conditions ^[2]. Beyond this, source-backed detail on additional high-risk groups is not yet available in the provided material ^[3].

Prevention in the source material focuses on vaccination and post-exposure wound care, with immunization described as extremely effective and key to prevention ^[3][2]. The maternal and neonatal tetanus elimination initiative is specifically linked to major reductions in neonatal tetanus mortality ^[3][1]. The snippets also indicate that neonatal tetanus prevention is associated with avoiding unhygienic childbirth practices and with proper immunization of pregnant mothers ^[2].

In surveillance terms, neonatal tetanus should be read as a preventable indicator of gaps in maternal immunization, childbirth hygiene, and access to effective prevention measures ^[2][3]. The disease appears now to be rare in high-income countries, while remaining a concern in lower-resource settings and in regions where tetanus morbidity and mortality persist ^[1]. Source-backed detail on case definitions, reporting thresholds, or routine surveillance case ascertainment is not yet available in these snippets ^[1][3].

1. 1 Sudarshan R et al. Tetanus: recognition and management. Lancet Infect Dis. 2025 Nov. PMID: 40543524. doi: 10.1016/S1473-3099(25)00292-0. PubMed: https://pubmed.ncbi.nlm.nih.gov/40543524/
2. 2 Bhatia R et al. Tetanus. Neurol India. 2002 Dec. PMID: 12577086. PubMed: https://pubmed.ncbi.nlm.nih.gov/12577086/
3. 3 Thwaites CL et al. Eradication of tetanus. Br Med Bull. 2015. PMID: 26598719. doi: 10.1093/bmb/ldv044. PubMed: https://pubmed.ncbi.nlm.nih.gov/26598719/
4. 4 Neonatal tetanus. Pediatric Emergency Medicine Journal. 2021. doi: 10.22470/pemj.2021.00269. DOI: https://doi.org/10.22470/pemj.2021.00269
5. 5 Neonatal Tetanus. BMJ. 1963. doi: 10.1136/bmj.1.5333.818. DOI: https://doi.org/10.1136/bmj.1.5333.818
6. 6 Neonatal Tetanus. Neonatal Orthopaedics. 2013. doi: 10.5005/jp/books/11784_37. DOI: https://doi.org/10.5005/jp/books/11784_37

ICD-10

A33

ICD-11

1C13

Total cases

5K

Total deaths

311

Peak month

2010-09

Coverage

2 reporting countries · 2014-04-01 → 2026-05-01